Skip to main content

BioApex, s.r.o.

Our mission

To improve patients’ quality of lives through the discovery, development and commercialization of innovative cancer and viral treatments with proven clinical benefits.

Our Vision

BioApex is a private biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism- targeted drugs to treat serious cell cycle related disorders, including cancer and viral diseases.

Our goals are to

  1. research and develop a broad portfolio of low molecular weight compounds that are novel and prove highly effective in fighting certain cancers and virus-induced cancerous cells,
  2. back our compounds with comprehensive patents,
  3. partner with industry leaders in the cost-intensive stages of drug development and marketing, and
  4. become a profitable and recognized leader in the areas of our focus and vital partner for “big pharma.”


In addition to our R&D efforts on cancer and virus related therapies BioApex also develops, manufactures and sells three product groups:

  • active pharmaceutical ingredients
  • chemical intermediates
  • fine chemicals

The Project is co-financed by the European Regional Development Fund and Czech Ministry of Industry and Trade